Literature DB >> 15717872

Renal damage in patients with Type 2 diabetes: a strong predictor of mortality.

S Bo1, G Ciccone, R Rosato, R Gancia, G Grassi, F Merletti, G F Pagano.   

Abstract

AIMS: (i) To compare mortality rates in a cohort of Type 2 diabetic patients with those of the general population; (ii) to assess the prognostic role of pre-existing chronic conditions; (iii) to evaluate the impact of different severity of renal damage on mortality.
METHODS: All 3892 patients with Type 2 diabetes attending our Diabetic Clinic during 1995 and alive on 1 January 1996 were identified and followed for 4.5 years. Information on vital status (100% complete) and causes of death (98.5% complete) for 599 deceased subjects was derived from death certificates.
RESULTS: In comparison with the general population, standardized mortality ratios (x 100) were: 125 (95% confidence interval 104-148) in patients aged < 75 and 85 (75-95) in patients > or = 75 years. Cardiovascular diseases and diabetes were responsible for most of the excess deaths. In a Cox-proportional hazard model, renal damage was a powerful predictor of death (hazard ratio = 2.39; 95% confidence intervals = 2.00-2.85). The severity of renal damage was associated with increasing hazard ratios for death from all-cause mortality and from specific causes (especially coronary artery disease, other cardiovascular causes and diabetes) after multiple adjustments. Other significant predictors of death were: greater age, glycated haemoglobin, smoking, lower body mass index, pre-existing coronary and peripheral artery disease and known co-morbidity (cirrhosis and cancer).
CONCLUSIONS: Renal damage of any severity is significantly associated with subsequent mortality from all causes and from cardiovascular diseases. These associations are not confounded by pre-existing co-morbidity or coronary diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15717872     DOI: 10.1111/j.1464-5491.2004.01394.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  6 in total

1.  Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement.

Authors:  Sheri R Colberg; Ronald J Sigal; Bo Fernhall; Judith G Regensteiner; Bryan J Blissmer; Richard R Rubin; Lisa Chasan-Taber; Ann L Albright; Barry Braun
Journal:  Diabetes Care       Date:  2010-12       Impact factor: 19.112

Review 2.  Approaches to prevention of cardiovascular complications and events in diabetes mellitus.

Authors:  Sergio Coccheri
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Endothelial dysfunction in geriatric diabetic patients: the role of microalbuminuria in elderly type 2 diabetic patients? A randomized controlled study.

Authors:  Mohamed A Helaly; Hussein A Sheashaa; El Sayed Z Hatata; Ansaf B Youssef; Asmaa Hegazi; Ibrahim A Abdel-Aal
Journal:  Int Urol Nephrol       Date:  2006-09-20       Impact factor: 2.266

4.  A four-year cardiovascular risk score for type 2 diabetic inpatients.

Authors:  Dolores Ramírez-Prado; Antonio Palazón-Bru; David Manuel Folgado-de la Rosa; María Ángeles Carbonell-Torregrosa; Ana María Martínez-Díaz; Damian Robert James Martínez-St John; Vicente Francisco Gil-Guillén
Journal:  PeerJ       Date:  2015-06-02       Impact factor: 2.984

5.  The impact of a multidisciplinary self-care management program on quality of life, self-care, adherence to anti-hypertensive therapy, glycemic control, and renal function in diabetic kidney disease: A Cross-over Study Protocol.

Authors:  Nancy Helou; Dominique Talhouedec; Maya Shaha; Anne Zanchi
Journal:  BMC Nephrol       Date:  2016-07-19       Impact factor: 2.388

6.  Risk of all-cause and CHD mortality in women versus men with type 2 diabetes: a systematic review and meta-analysis.

Authors:  Guodong Xu; Dingyun You; Liping Wong; Donghui Duan; Fanqian Kong; Xiaohong Zhang; Jinshun Zhao; Wenhua Xing; Liyuan Han; Li Li
Journal:  Eur J Endocrinol       Date:  2019-04       Impact factor: 6.664

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.